2 withdrawn. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Withdrawn 2 |
Follow Peritoneal Neoplasms: new trials by email Literature Review of Peritoneal Neoplasms trials Research Report on Peritoneal Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Perioperative Chemotherapy With Bevacizumab for Colorectal Carcinomatosis French Part of the Main Bev-IP Study Cytoreductive surgery combined with HIPEC, bevacizumab and HIPEC (Oxaliplatin 360 mg/m2). - Colorectal Carcinomatosis | Phase 2 | Withdrawn | Hospices Civils de Lyon | 2018-09-21 | 2018-11-14 | |
| Prospective Randomized Trial Evaluating Mandatory Second Look Surgery With HIPEC and CRS vs. Standard of Care in Subjects at High Risk of Developing Colorectal Peritoneal Metastases Laparotomy+ HIPEC +/- CRS - Colorectal Carcinoma, Peritoneal Carcinomatosis | Phase 2 | Withdrawn | National Cancer Institute (NCI) | 2010-01-14 | 2017-07-02 |
Colonic Neoplasms (1) · Colorectal Neoplasms (1) · Neoplasm Metastasis (1) · Rectal Neoplasms (1) · Recurrence (1)
Abdominal Neoplasms (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Neoplasms (2) · Neoplasms by Site (2) · Peritoneal Diseases (2) · Colonic Diseases (1) · Disease Attributes (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Intestinal Diseases (1) · Intestinal Neoplasms (1) · Neoplastic Processes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Bevacizumab (1) · Hyperthermic Intraperitoneal Chemotherapy (1) · Oxaliplatin (1)
Hospices Civils de Lyon (1) · National Cancer Institute (NCI) (1)
United States (1)